ACLA Press Releases

  • More than 60 Leading Health Care Organizations Call on CMS to Maintain Coverage for Medically Necessary Cancer Testing

    February 01, 2019
    Overly broad interpretation of national coverage determination for next generation sequencing restricts Medicare beneficiary access to vital testing and adversely impacts cancer care  WASHINGTON, DC – February 1, 2019 – Leading health care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare and Medicaid Services (CMS) to revise its interpretation of the National Coverage DeterminationContinue Reading »...
  • ACLA Statement on GAO Analysis & Medicare Lab Payments

    January 25, 2019
    Latest report reflects misleading, inaccurate assumptions on Medicare lab billing & payment  Washington, D.C. – Following the recent release of the Government Accountability Office’s (GAO) report on billing and reimbursement for clinical lab tests under the Medicare program, Julie Khani, President of the American Clinical Laboratory Association (ACLA), issued the following statement: “GAO’s conclusions on overbilling of laboratory services in the Medicare program are fundamentallyContinue Reading »...
  • ACLA Expands Policy, Government Affairs Teams with Joan Kegerize, Liz Thomas

    January 22, 2019
    Kegerize to help lead ACLA’s policy work related to reimbursement & scientific affairs; Thomas to support industry’s broader advocacy and federal affairs priorities  Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced two new additions to the Association’s policy and advocacy teams. Joan Kegerize, who previously served as a principal consultant for GMBI Consulting, will serve as Vice President of Reimbursement andContinue Reading »...
  • ACLA Announces Historian and Author Doris Kearns Goodwin as Keynote Speaker for 2019 Annual Meeting

    December 17, 2018
    Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced that Doris Kearns Goodwin, world-renowned presidential historian, public speaker and Pulitzer Prize-winning author, will serve as the keynote speaker for the organization’s annual meeting on March 26, 2019. Goodwin, who published her most recent book Leadership in Turbulent Times, will offer insight and perspective on the historical political landscape and how it continuesContinue Reading »...
  • ACLA Files Appeal in ACLA v. Azar, Asks U.S. Court of Appeals to Address HHS’s Overreach in Data Reporting

    December 04, 2018
    HHS’s continued flawed implementation of PAMA threatens beneficiaries’ access to critical lab services Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) advanced its case against the U.S. Department of Health and Human Services’ (HHS) flawed and harmful implementation of the Protecting Access to Medicare Act (PAMA). ACLA’s opening brief argues that HHS has exceeded its statutory authority, circumventing Congress’ stated directive ofContinue Reading »...
  • ACLA Statement on Final 2019 Medicare Payment Policies

    November 02, 2018
    Final rule takes preliminary steps to correct flawed data collection process; urgent Congressional action needed to protect millions of seniors from continued cuts to essential Medicare lab services   Washington, D.C. – Following the release of final Medicare payment policies, Julie Khani, President of the American Clinical Laboratory Association (ACLA) issued the following statement regarding new policy changes related to implementation of the Protecting AccessContinue Reading »...
  • ACLA Statement on Notice of Appeal in ACLA v. Azar

    October 19, 2018
    HHS’s continued reliance on faulty data collection process jeopardizes access to critical lab tests for millions of beneficiaries; ACLA files appeal following District Court decision  Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) filed its notice of appeal in its lawsuit against the U.S. Department of Health and Human Services (HHS) challenging its implementation of the Protecting Access to Medicare Act (PAMA),Continue Reading »...
  • ACLA Statement on District Court Opinion in Lawsuit Against HHS

    September 24, 2018
    Lawsuit targeted HHS’ unlawful implementation of 2014 Medicare legislation, regulatory guidance that would jeopardize beneficiaries’ access to critical lab services Washington, D.C. – Following the opinion from the U.S. District Court for the District of Columbia in ACLA v. Azar, Julie Khani, ACLA President, issued the following statement: “This is an extremely disappointing outcome for ACLA’s members and the millions of seniors they serveContinue Reading »...
  • Press Release; ACLA Submits Comments to Proposed 2019 Medicare Payment Policies

    September 11, 2018
    ...
  • ACLA Calls on CMS to Address Questionable Medicare Utilization Practices Through Stronger ‘Stark Law’ Provisions

    August 28, 2018
    Washington, D.C. – In a new comment letter to the Centers for Medicare & Medicaid Services (CMS), the American Clinical Laboratory Association called on the agency to address the long-standing abuse of the physician self-referral law (“Stark Law”) that has lead to persistent overutilization of specific services across the Medicare program. While CMS’ Request For Information on the Stark Law largely centered on howContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15